205 GENES FOUNDi
Show / hide columns XML | RDF | TSV | Page of 5 | next »
Genei Gene descriptioni x Protein classi x Tissue Cell Pathology Subcellular locationi x Prognostic p-valuei x RNA tissue categoryi x
ABHD3Abhydrolase domain containing 3Enzymes
Predicted intracellular proteins
Predicted membrane proteins
Nucleus
Vesicles
Plasma membrane
Melanoma: 8.52e-4
Expressed in all
ACP1Acid phosphatase 1, solubleEnzymes
Plasma proteins
Predicted intracellular proteins
Nucleus
Cytosol
Liver cancer: 6.67e-6
Melanoma: 3.04e-4
Expressed in all
ADH5Alcohol dehydrogenase 5 (class III), chi polypeptideEnzymes
Plasma proteins
Predicted intracellular proteins
Renal cancer: 4.58e-10
Endometrial cancer: 9.90e-5
Melanoma: 3.54e-4
Expressed in all
ALPLAlkaline phosphatase, liver/bone/kidneyCancer-related genes
Disease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
CytosolMelanoma: 7.08e-4
Tissue enhanced
ANAPC10Anaphase promoting complex subunit 10Predicted intracellular proteins
Nucleoplasm
Golgi apparatus
Melanoma: 8.22e-4
Expressed in all
ANGPT2Angiopoietin 2Cancer-related genes
Plasma proteins
Predicted secreted proteins
RAS pathway related proteins
Renal cancer: 1.52e-7
Liver cancer: 6.36e-5
Cervical cancer: 7.99e-5
Stomach cancer: 3.87e-4
Melanoma: 4.48e-4
Mixed
ANKRD12Ankyrin repeat domain 12Cancer-related genes
Predicted intracellular proteins
Nucleoplasm
Cytosol
Melanoma: 6.71e-4
Expressed in all
B9D2B9 protein domain 2Disease related genes
Predicted intracellular proteins
Melanoma: 6.39e-4
Mixed
BCL2L1BCL2 like 1Cancer-related genes
Predicted intracellular proteins
Predicted membrane proteins
RAS pathway related proteins
Transporters
MitochondriaRenal cancer: 8.89e-5
Pancreatic cancer: 5.87e-4
Endometrial cancer: 9.10e-4
Melanoma: 9.57e-4
Expressed in all
BCL3B-cell CLL/lymphoma 3Cancer-related genes
Disease related genes
Plasma proteins
Predicted intracellular proteins
Transcription factors
Nucleoplasm
Vesicles
Midbody
Renal cancer: 3.13e-14
Melanoma: 3.74e-4
Glioma: 5.58e-4
Breast cancer: 9.67e-4
Expressed in all
BRD7Bromodomain containing 7Predicted intracellular proteins
Nucleoplasm
Cytosol
Renal cancer: 1.55e-4
Melanoma: 5.38e-4
Expressed in all
C15orf39Chromosome 15 open reading frame 39Predicted intracellular proteins
CytosolRenal cancer: 3.05e-4
Testis cancer: 6.02e-4
Melanoma: 7.94e-4
Tissue enhanced
C16orf74Chromosome 16 open reading frame 74Predicted intracellular proteins
Plasma membrane
Centrosome
Pancreatic cancer: 1.54e-5
Head and neck cancer: 1.71e-4
Melanoma: 4.08e-4
Mixed
C1orf174Chromosome 1 open reading frame 174Predicted intracellular proteins
NucleusRenal cancer: 2.73e-6
Liver cancer: 5.84e-4
Melanoma: 7.62e-4
Expressed in all
C1orf50Chromosome 1 open reading frame 50Predicted intracellular proteins
Melanoma: 4.65e-4
Expressed in all
C21orf58Chromosome 21 open reading frame 58Predicted intracellular proteins
Nucleoplasm
Nuclear bodies
Pancreatic cancer: 4.20e-4
Head and neck cancer: 7.00e-4
Melanoma: 7.48e-4
Tissue enhanced
C2orf88Chromosome 2 open reading frame 88Predicted intracellular proteins
Endometrial cancer: 4.97e-4
Renal cancer: 7.79e-4
Melanoma: 9.39e-4
Expressed in all
C8orf88Chromosome 8 open reading frame 88Predicted intracellular proteins
Urothelial cancer: 6.23e-6
Melanoma: 4.90e-4
Tissue enhanced
CALD1Caldesmon 1Plasma proteins
Predicted intracellular proteins
Plasma membrane
Actin filaments
Renal cancer: 1.84e-5
Melanoma: 3.73e-4
Tissue enhanced
CCL4C-C motif chemokine ligand 4Cancer-related genes
Predicted secreted proteins
Endometrial cancer: 1.97e-5
Renal cancer: 1.68e-4
Colorectal cancer: 3.54e-4
Melanoma: 3.97e-4
Tissue enhanced
CCL5C-C motif chemokine ligand 5Cancer-related genes
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Renal cancer: 3.61e-7
Endometrial cancer: 1.34e-5
Melanoma: 2.42e-4
Tissue enhanced
CCNB2Cyclin B2Cancer-related genes
Plasma proteins
Predicted intracellular proteins
Transporters
Golgi apparatus
Cytosol
Renal cancer: 0.00e+0
Pancreatic cancer: 1.74e-5
Melanoma: 3.21e-5
Liver cancer: 2.83e-4
Lung cancer: 4.63e-4
Tissue enhanced
CD2CD2 moleculeCD markers
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Renal cancer: 4.82e-6
Endometrial cancer: 1.69e-5
Melanoma: 3.97e-5
Head and neck cancer: 7.46e-5
Cervical cancer: 1.47e-4
Breast cancer: 4.36e-4
Ovarian cancer: 7.72e-4
Tissue enhanced
CD27CD27 moleculeCancer-related genes
CD markers
Disease related genes
Plasma proteins
Predicted membrane proteins
Head and neck cancer: 6.65e-7
Renal cancer: 1.19e-6
Cervical cancer: 3.77e-5
Endometrial cancer: 2.90e-4
Melanoma: 5.50e-4
Tissue enhanced
CD3ECD3e moleculeCD markers
Disease related genes
FDA approved drug targets
Predicted membrane proteins
Endometrial cancer: 2.30e-6
Renal cancer: 1.12e-5
Melanoma: 1.18e-4
Head and neck cancer: 1.32e-4
Cervical cancer: 1.62e-4
Breast cancer: 1.72e-4
Tissue enhanced
CD5CD5 moleculeCD markers
Predicted membrane proteins
Predicted secreted proteins
Head and neck cancer: 7.41e-6
Renal cancer: 8.94e-5
Endometrial cancer: 9.00e-5
Cervical cancer: 9.16e-5
Melanoma: 3.93e-4
Breast cancer: 4.05e-4
Tissue enhanced
CD7CD7 moleculeCD markers
Predicted membrane proteins
Predicted secreted proteins
Renal cancer: 7.75e-11
Endometrial cancer: 2.03e-5
Melanoma: 2.69e-4
Cervical cancer: 5.51e-4
Tissue enhanced
CDC5LCell division cycle 5 likeDisease related genes
Plasma proteins
Predicted intracellular proteins
Transcription factors
NucleoplasmMelanoma: 7.02e-5
Expressed in all
CDCA7Cell division cycle associated 7Disease related genes
Predicted intracellular proteins
Nucleoplasm
Cytosol
Liver cancer: 4.20e-4
Melanoma: 5.50e-4
Mixed
CDCA8Cell division cycle associated 8Predicted intracellular proteins
Nucleus
Nucleoli
Cytokinetic bridge
Renal cancer: 0.00e+0
Liver cancer: 4.93e-10
Melanoma: 6.04e-4
Pancreatic cancer: 8.32e-4
Tissue enhanced
CDK11ACyclin dependent kinase 11AEnzymes
Predicted intracellular proteins
Nuclear speckles
Cytosol
Renal cancer: 1.15e-6
Melanoma: 5.06e-4
Expressed in all
CDYLChromodomain Y-likeEnzymes
Predicted intracellular proteins
Nuclear specklesGlioma: 2.10e-4
Liver cancer: 2.20e-4
Melanoma: 7.52e-4
Expressed in all
CENPLCentromere protein LPredicted intracellular proteins
Melanoma: 2.51e-4
Ovarian cancer: 3.60e-4
Tissue enhanced
CHTOPChromatin target of PRMT1Plasma proteins
Predicted intracellular proteins
Nuclear specklesRenal cancer: 2.02e-4
Urothelial cancer: 2.69e-4
Melanoma: 4.08e-4
Liver cancer: 4.85e-4
Expressed in all
CKS1BCDC28 protein kinase regulatory subunit 1BCancer-related genes
Predicted intracellular proteins
Nucleus
Vesicles
Mitochondria
Cytosol
Renal cancer: 6.03e-7
Liver cancer: 2.94e-5
Melanoma: 3.12e-5
Thyroid cancer: 4.87e-4
Pancreatic cancer: 6.13e-4
Endometrial cancer: 7.89e-4
Expressed in all
CNOT2CCR4-NOT transcription complex subunit 2Predicted intracellular proteins
Nucleus
Cytosol
Renal cancer: 8.63e-5
Liver cancer: 2.21e-4
Melanoma: 6.86e-4
Expressed in all
COX14COX14, cytochrome c oxidase assembly factorDisease related genes
Predicted membrane proteins
MitochondriaMelanoma: 7.90e-4
Expressed in all
CXCR3C-X-C motif chemokine receptor 3CD markers
G-protein coupled receptors
Predicted membrane proteins
Renal cancer: 1.67e-6
Endometrial cancer: 3.44e-6
Melanoma: 2.90e-4
Head and neck cancer: 3.35e-4
Tissue enhanced
DARSAspartyl-tRNA synthetaseDisease related genes
Enzymes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
CytosolLiver cancer: 2.39e-6
Renal cancer: 1.24e-5
Pancreatic cancer: 6.54e-4
Melanoma: 7.57e-4
Expressed in all
DBF4DBF4 zinc fingerPredicted intracellular proteins
Nucleus
Nuclear bodies
Renal cancer: 6.42e-7
Liver cancer: 4.45e-6
Melanoma: 6.86e-4
Tissue enriched
DHX9DExH-box helicase 9Cancer-related genes
Enzymes
Plasma proteins
Predicted intracellular proteins
NucleusLiver cancer: 3.17e-4
Melanoma: 6.04e-4
Expressed in all
DKC1Dyskerin pseudouridine synthase 1Disease related genes
Plasma proteins
Predicted intracellular proteins
Nucleus
Nucleoli fibrillar center
Renal cancer: 1.46e-9
Liver cancer: 1.39e-5
Endometrial cancer: 2.66e-5
Head and neck cancer: 2.94e-4
Melanoma: 9.13e-4
Expressed in all
DLGAP4DLG associated protein 4Predicted intracellular proteins
Nucleoplasm
Focal adhesion sites
Cytosol
Liver cancer: 3.73e-6
Endometrial cancer: 2.24e-5
Melanoma: 9.88e-5
Renal cancer: 2.48e-4
Expressed in all
DNAJC22DnaJ heat shock protein family (Hsp40) member C22Predicted membrane proteins
VesiclesEndometrial cancer: 4.56e-5
Melanoma: 7.54e-4
Mixed
DOK2Docking protein 2Predicted intracellular proteins
Renal cancer: 2.20e-4
Melanoma: 4.31e-4
Mixed
DRAM2DNA damage regulated autophagy modulator 2Predicted membrane proteins
Golgi apparatus
Vesicles
Liver cancer: 3.45e-5
Melanoma: 6.43e-4
Renal cancer: 7.45e-4
Mixed
DSCC1DNA replication and sister chromatid cohesion 1Predicted intracellular proteins
NucleoplasmLiver cancer: 3.92e-6
Lung cancer: 3.93e-4
Melanoma: 5.73e-4
Mixed
EEF1B2Eukaryotic translation elongation factor 1 beta 2Plasma proteins
Predicted intracellular proteins
Nucleoli fibrillar center
Cytosol
Renal cancer: 3.62e-6
Breast cancer: 2.60e-4
Melanoma: 9.95e-4
Expressed in all
EFNB1Ephrin B1Cancer-related genes
Disease related genes
Plasma proteins
Predicted membrane proteins
Plasma membraneEndometrial cancer: 3.32e-5
Pancreatic cancer: 4.29e-4
Melanoma: 8.68e-4
Mixed
EGR3Early growth response 3Predicted intracellular proteins
Transcription factors
Nucleus
Vesicles
Breast cancer: 1.83e-4
Melanoma: 4.78e-4
Mixed
Page of 5 | next »